MedTrace Logo

Polyunsaturates and KCL to Control Mild Hypertension

NCT00000511 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2013-12-13

No results posted yet for this study

Summary

To test the efficacy of omega-3 fatty acids in untreated mild hypertensives and magnesium, calcium, and potassium supplementation supplementation in non-hypertensives. These clinical trials were conducted in sequence over a four year period.

Conditions

Interventions

DIETARY_SUPPLEMENT

mineral supplements

DIETARY_SUPPLEMENT

Trial 1: fatty acids, omega-3; Trial 2: Mineral supplements

BEHAVIORAL

dietary supplements

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Brigham and Women's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1983-12-31
Primary Completion
1994-11-30
Completion
1994-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000511 on ClinicalTrials.gov